MNPR Stock Earnings: Monopar Therapeutics Misses EPS for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
MNPR stock results show that Monopar Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
The post MNPR Stock Earnings: Monopar Therapeutics Misses EPS for Q2 2024 appeared first on InvestorPlace.
More From InvestorPlace